BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 1243823)

  • 1. [Prevention of postpartum lactation using a new ergot derivative: 2-Br-alpha-ergocryptine or CB-154. Comparison with chlorotrianisene].
    Dexeus Trias de Bes J
    Gynakol Rundsch; 1975; 15(1):91-6. PubMed ID: 1243823
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of bromocriptine and chlorotrianisene on inhibition of lactation and serum prolactin. A comparative double-blind study.
    Utian WH; Begg G; Vinik AI; Paul M; Shuman L
    Br J Obstet Gynaecol; 1975 Sep; 82(9):755-9. PubMed ID: 1101946
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An ergocryptine as a lactation inhibitor.
    Falzon MD; Galea R; Cmailleri AP
    Gynecol Invest; 1974; 5(3):133-8. PubMed ID: 4615051
    [No Abstract]   [Full Text] [Related]  

  • 4. Inhibition of puerperal lactation. Double-blind comparison of chlorotrianesene, testosterone enanthate with estradiol valerate and placebo.
    Morris JA; Creasy RK; Hohe PT
    Obstet Gynecol; 1970 Jul; 36(1):107-14. PubMed ID: 4912251
    [No Abstract]   [Full Text] [Related]  

  • 5. Prevention of postpartum breast engorgement: double-blind comparison of chlorotrianisene 72 mg. and placebo.
    Phillips WP
    J Ark Med Soc; 1975 Sep; 72(4):163-7. PubMed ID: 127773
    [No Abstract]   [Full Text] [Related]  

  • 6. A comparative study of two fat-stored oestrogens in inhibiting lactation.
    King MK
    Br J Clin Pract; 1972 Jun; 26(6):267-70. PubMed ID: 4557896
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of Lisuride on serum prolactin levels during puerperium.
    Venturini PL; Maganza C; Massimilla A; Campanella P; Rossato P; Ragni N; De Cecco L
    Acta Eur Fertil; 1979 Jun; 10(2):51-5. PubMed ID: 545976
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Postpartal lactation inhibition by 2-Br-alpha-ergocryptine: II. A comparative study with 2-Br-alpha-ergocryptine and methallenoestrol (author's transl)].
    Varga L; Radielovic P
    Geburtshilfe Frauenheilkd; 1974 Oct; 34(10):885-7. PubMed ID: 4442688
    [No Abstract]   [Full Text] [Related]  

  • 9. [Report on the use of chlorotrianisene (TACE) as inhibitor of lactation].
    Hechtermans R
    Bull Soc R Belge Gynecol Obstet; 1967; 37(2):147-54. PubMed ID: 5596754
    [No Abstract]   [Full Text] [Related]  

  • 10. A double-blind trial of chlorotrianisene in the suppression of lactation.
    Binns DT
    Practitioner; 1967 Nov; 199(193):685-8. PubMed ID: 4863299
    [No Abstract]   [Full Text] [Related]  

  • 11. [2-Br-alpha-ergocryptine (Parlodel) in primary and secondary lactation suppression following child-birth or abortion (author's transl)].
    Gehring H; Fischer S; Hofer U
    Schweiz Rundsch Med Prax; 1977 Aug; 66(31):985-9. PubMed ID: 556441
    [No Abstract]   [Full Text] [Related]  

  • 12. Prolactin inhibition and suppression of puerperal lactation by a Br-erocryptine (CB 154). A comparison with estrogen.
    Brun del Re R; Del Pozo E; De Grandi P; Friesen H; Hinselmann M; Wyss H
    Obstet Gynecol; 1973 Jun; 41(6):884-90. PubMed ID: 4708482
    [No Abstract]   [Full Text] [Related]  

  • 13. [Effect of Lysenyl on lactation during the puerperium (author's transl)].
    Stríbrný J; Hájek Z; Papez L; Burdová M; Filipovicová M; Rezábek K
    Cesk Gynekol; 1973 Nov; 38(9):688-9. PubMed ID: 4765173
    [No Abstract]   [Full Text] [Related]  

  • 14. A comparison of 2 bromo alpha ergocryptine, quinoestrol and placebo in suppression of puerperal lactation [proceedings].
    Walker S
    Br J Clin Pharmacol; 1975 Aug; 2(4):368P-369P. PubMed ID: 788734
    [No Abstract]   [Full Text] [Related]  

  • 15. The treatment of puerperal lactation with bromocriptine.
    Cooke I; Foley M; Lenton E; Preston E; Millar D; Jenkins A; Obiekwe B; McNeilly A; Parsons J; Kennedy G
    Postgrad Med J; 1976; 52suppl 1():75-80. PubMed ID: 959129
    [No Abstract]   [Full Text] [Related]  

  • 16. [Use of methergoline in inhibition of puerperal lactation].
    Iannotta F; Berra G
    Minerva Ginecol; 1979 May; 31(5):399-404. PubMed ID: 572517
    [No Abstract]   [Full Text] [Related]  

  • 17. [Use of bromoergocryptine in physiological inhibition of lactation].
    Canales ES; Levinson G; González-Colindres J; de la Peña RO; Zárate A
    Ginecol Obstet Mex; 1975 Feb; 37(220):49-52. PubMed ID: 1123159
    [No Abstract]   [Full Text] [Related]  

  • 18. [Mechanism of action of estrogens and clomiphene in the inhibition of lactation].
    Andreoli C; Furbatto G
    Minerva Ginecol; 1977; 29(7-8):539-42. PubMed ID: 563026
    [No Abstract]   [Full Text] [Related]  

  • 19. The suppression of puerperal lactation with bromocriptine.
    O'Donoghue RF
    Ir Med J; 1977 Apr; 70(5):172-3. PubMed ID: 324946
    [No Abstract]   [Full Text] [Related]  

  • 20. [Prevention of lactation with a new ergot derivative, CB-154. Comparison with ablacton].
    Mendes ML
    Brux Med; 1974 Dec; 54(12):737-41. PubMed ID: 4474051
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.